Filing Flows › Officials › Terri A. Sewell
Terri A. Sewell (D-AL): disclosed stock trades
Representative Terri A. Sewell's disclosed stock trades: 4 on file, the scored ones averaging +11.5% against SPY over the 63 trading days after disclosure; committees: Joint Committee on Printing, House Committee on Ways and Means, House Committee on House Administration.
Committees
- Joint Committee on Printing
- House Committee on Ways and Means
- House Committee on House Administration
Trades in sectors under their committees
A trade in a sector that one of the member’s committees oversees (the map is published with the data). A fact pattern from public disclosures, not a finding of wrongdoing.
| Date | Ticker | Type | Amount | Committee | Area |
|---|---|---|---|---|---|
| 2026-03-25 | GEHC | sale | $1,001–$15,000 | House Committee on Ways and Means | health care (Medicare) |
Recent disclosed trades
| Date | Ticker | Type | Amount | Owner | Filed |
|---|---|---|---|---|---|
| 2026-03-25 | GEHC | sale | $1,001–$15,000 | Self | 2026-04-21 |
| 2026-03-25 | TPR | sale | $15,001–$50,000 | Self | 2026-04-21 |
Every trade on file and how it did
| Traded | Ticker | Side | Amount (middle of the range) | Disclosed | Stock vs SPY, 63 days after disclosure | Right side? |
|---|---|---|---|---|---|---|
| 2026-03-25 | GEHC | Sold | about $8K | 2026-04-21 | -17.0% | yes |
| 2026-03-25 | TPR | Sold | about $33K | 2026-04-21 | -8.6% | yes |
| 2025-04-10 | AAPL | Bought | about $8K | 2025-05-12 | -0.3% | no |
| 2025-04-10 | NVDA | Bought | about $8K | 2025-05-12 | +29.9% | yes |
A purchase is on the right side when the stock then beat SPY, a sale when it lagged; a dash: not 63 trading days on yet, or no price on file.
Performance: each scored trade’s stock return less SPY’s over the 63 trading days after it was disclosed (a sale counts when the stock then lagged), weighted by the middle of the reported amount range, 2025-04-10 to 2026-03-25.
Source: House and Senate periodic transaction reports; committees from the congress-legislators project. Not investment advice.